Across TCGA pan-cancer cohorts, ZSWIM2 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated ZSWIM2 data layer compared with 3 for mutation status.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher ZSWIM2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZSWIM2 expression acts as an unfavorable survival marker, although some lineages such as PAAD show a favorable association.
KIRP, KICH, and UCEC are the cancer types where ZSWIM2 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.